您好,欢迎您

【2018ASH抢先看】大会召开在即!中国好声音即将唱响!

2018年11月28日
研究进展
整理:肿瘤资讯
来源:肿瘤资讯

2018年12月1-4日,第60届美国血液学年会(ASH)将于美国·圣地亚哥隆重召开。每年的ASH无疑是众咖齐聚、精彩纷呈。随着中国肿瘤医学的发展,越来越多的中国学者相继登上这个顶级盛会的舞台。今年,将有哪些“中国声音”入选ASH口头报告呢?跟随小编一起来看看吧!

2E5E9E7C-7172-495D-9709-B5BEC6EECEDA.png

当地时间:12月1日

72 Myeloid-Derived Suppressor Cells (HLA-DR-/lowCD16-CD33+) Expanded By Granulocyte Colony-Stimulating Factor Can Prevent Acute Graft-Versus-Host Disease in Humanized Mouse and Patients Following HSCT

讲者:北京大学血液学研究所  王柯

时间:12月1日 8:45 AM

地点:Grand Hall B (Manchester Grand Hyatt San Diego)

链接:https://ash.confex.com/ash/2018/webprogram/Paper114291.html

76 Endothelial O-Glycoproteins Cooperate with Platelet CLEC-2 Signaling to Maintain Cerebrovascular Integrity during Mouse Development

讲者:苏州大学附属第一医院  傅建新

时间:12月1日 10:15 AM

地点:Room 28D (San Diego Convention Center)

链接:https://ash.confex.com/ash/2018/webprogram/Paper118929.html

148 Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial

讲者:北京大学肿瘤医院 宋玉琴

时间:12月1日 12:45 PM

地点:Pacific Ballroom 20 (Marriott Marquis San Diego Marina)

链接:https://ash.confex.com/ash/2018/webprogram/Paper117956.html

212 The Novel Berbamine Derivative, Cbbm, Downregulates c-Myc to Block Diffuse Large B-Cell Lymphoma Cell Maintenance

讲者:浙江大学医学院附属邵逸夫医院  张蕾

时间:12月1日 2:15 PM

地点:Room 7B (San Diego Convention Center)

链接:https://ash.confex.com/ash/2018/webprogram/Paper112006.html

192 High Expression of NEK2 Mediated By p53 Contributes to Progression and Relapse of Multiple Myeloma

讲者:中国医学科学院北京协和医学院血液学研究所 周文

时间:12月1日 3:15 PM

地点:Grand Ballroom 7 (Marriott Marquis San Diego Marina)

链接:https://ash.confex.com/ash/2018/webprogram/Paper116155.html 

199 A Novel Recombinant Human Thrombopoietin Therapy for Promoting Platelet Engraftment in Haematological Malignancies after Single Umbilical Cord Blood Transplantation: A Prospective Randomized Controlled Trial

讲者:中国科技大学附属第一医院 朱小玉

时间:12月1日 2:00 PM

地点:Grand Hall B (Manchester Grand Hyatt San Diego)

链接:https://ash.confex.com/ash/2018/webprogram/Paper118195.html

当地时间:12月2日

277 A Feasibility and Safety Study of CD19 and CD22 Chimeric Antigen Receptors-Modified T Cell Cocktail for Therapy of B Cell Acute Lymphoblastic Leukemia

讲者:陆道培医院 陆佩华

时间:12月2日7:30 AM

地点:Ballroom 20D (San Diego Convention Center)

链接:https://ash.confex.com/ash/2018/webprogram/Paper114415.html

280 Efficacy and Safety of CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphocytic Leukemia (B-cell ALL) in a Large Cohort Including Patients with Extramedullary Disease(EMD), High Leukemia Burden, BCR-ABL (+) Mutation,TP53 Mutation, and Post-Transplant Relapse

讲者:陆道培医院 张弦  

时间:12月2日 8:15 AM

地点:Ballroom 20D (San Diego Convention Center)

链接:https://ash.confex.com/ash/2018/webprogram/Paper115642.html

360 Poor NKG2C+ Adaptive NK Cell Recovery at Early Stage after Allo-HSCT Increased the Occurrence of Refractory Cytomegalovirus Infection

讲者:北京大学血液学研究所 余星星

时间:12月2日10:45 AM

地点:Grand Hall A (Manchester Grand Hyatt San Diego)

链接:https://ash.confex.com/ash/2018/webprogram/Paper115772.html

当地时间:12月3日

682 Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study

讲者:北京大学肿瘤医院 宋玉琴

时间:12月3日11:15 AM

地点:Room 6F (San Diego Convention Center) 

链接:https://ash.confex.com/ash/2018/webprogram/Paper117848.html

727 First-Line Therapy with Donor Derived HCMV-Specific T Cells Reduce Persistent HCMV Infection after Allogenic Stem Cell Transplantation

讲者:北京大学血液学研究所  赵翔宇

时间:12月3日 2:45 PM

地点:Room 8 (San Diego Convention Center)

链接:https://ash.confex.com/ash/2018/webprogram/Paper113923.html

791 Safety and Efficacy of HQP1351, a 3rd Generation Oral BCR-ABL Inhibitor in Patients with Tyrosine Kinase Inhibitor -Resistant Chronic Myelogenous Leukemia: Preliminary Results of Phase I Study

讲者:北京大学血液学研究所 江倩

时间:12月3日 3:45 PM

地点:Room 6E (San Diego Convention Center)

链接:https://ash.confex.com/ash/2018/webprogram/Paper119142.html

901 First-in-Human CLL1-CD33 Compound CAR T Cell Therapy Induces Complete Remission in Patients with Refractory Acute Myeloid Leukemia: Update on Phase 1 Clinical Trial

讲者:成都总医院造血干细胞移植中心 刘芳 

时间:12月3日  4:30 PM

地点:Seaport Ballroom F (Manchester Grand Hyatt San Diego)

链接:https://ash.confex.com/ash/2018/webprogram/Paper110579.html 

955 Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma

讲者:西安交大附属二院 赵万红 

时间:12月3日4:30 PM

地点:Ballroom 20A (San Diego Convention Center)

链接:https://ash.confex.com/ash/2018/webprogram/Paper110548.html

956 Durable Remission Achieved from Bcma-Directed CAR-T Therapy Against Relapsed or Refractory Multiple Myeloma

讲者:上海恒润达生生物科技有限公司 刘雅容

时间:12月3日 4:45 PM

地点:Ballroom 20A (San Diego Convention Center)

链接:https://ash.confex.com/ash/2018/webprogram/Paper112786.html 

960 Low Dose of Human scFv-Derived BCMA-Targeted CAR-T Cells Achieved Fast Response and High Complete Remission in Patients with Relapsed/Refractory Multiple Myeloma

讲者:温州医科大学附属第一医院 江松福

时间:12月3日 5:45 PM

地点:Ballroom 20A (San Diego Convention Center)

链接:https://ash.confex.com/ash/2018/webprogram/Paper113220.html

1009 Tandom Autologous Transplantation and Combined Infusion of CD19 and Bcma-Specific Chimeric Antigen Receptor T Cells for High Risk MM: Initial Safety and Efficacy Report from a Clinical Pilot Study

讲者:苏州大学附属第一医院 傅琤琤

时间:12月3日 6:15 PM

地点:Ballroom 20D (San Diego Convention Center)

链接:https://ash.confex.com/ash/2018/webprogram/Paper117964.html 

1013 T Cells Expressing Anti B-Cell Maturation Antigen Chimeric Antigen Receptors for Plasma Cell Malignancies

讲者:华中科技大学同济医学院同济医院 李春蕊

时间:12月3日 7:15 PM

地点:Ballroom 20D (San Diego Convention Center)

链接:https://ash.confex.com/ash/2018/webprogram/Paper116898.html

欢迎大家持续追踪后续报道。如有遗漏,敬请留言补充!

责任编辑:肿瘤资讯-Amiee
99%的血液淋巴瘤医生都已经加入良医汇交流群……
查看详情

评论
08月28日
陈熙
南华大学 | 衡阳医学院
学习
06月29日
赵艳秋
沈丘县人民医院 | 肿瘤内科
学习
06月26日
韩国娜
牡丹江市肿瘤医院 | 肿瘤内科
学习